Tamara Bozina

Zagreb, 10000, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical Practice.

Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical Practice.

Journal: Pharmaceutics

Published: June 06, 2026

ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice.

ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice.

Journal: Toxics

Published: February 27, 2026

Pharmacogenomics in the prediction of adverse effects of cardiovascular drugs: the PGx-CardioDrug project.

Pharmacogenomics in the prediction of adverse effects of cardiovascular drugs: the PGx-CardioDrug project.

Journal: Croatian medical journal

Published: January 11, 2026

Role of Genetic and Epigenetic Biomarkers in Treatment-Resistant Depression: A Literature Review.

Role of Genetic and Epigenetic Biomarkers in Treatment-Resistant Depression: A Literature Review.

Journal: Genes

Published: September 26, 2025

Common Methylenetetrahydrofolate Reductase Polymorphism MTHFR 677C>T (rs1801133), Plasma Homocysteine, and Non-Valvular Atrial Fibrillation in Overweight/Obese Patients: Causality Indicated by Mediation and One-Sample Mendelian Randomization Analysis.

Common Methylenetetrahydrofolate Reductase Polymorphism MTHFR 677C>T (rs1801133), Plasma Homocysteine, and Non-Valvular Atrial Fibrillation in Overweight/Obese Patients: Causality Indicated by Mediation and One-Sample Mendelian Randomization Analysis.

Journal: Diagnostics (Basel, Switzerland)

Published: September 24, 2025

Pharmacogenetics Approach for Personalized Tacrolimus Dosing in Heart Transplantation: A Case Report and Literature Review.

Pharmacogenetics Approach for Personalized Tacrolimus Dosing in Heart Transplantation: A Case Report and Literature Review.

Journal: Genes

Published: July 13, 2025

Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Journal: Genes

Published: April 14, 2024

Common P-glycoprotein (ABCB1) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events: Preliminary data.

Common P-glycoprotein (ABCB1) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events: Preliminary data.

Journal: Biochemia medica

Published: December 06, 2023

METOCLOPRAMIDE-INDUCED ACUTE DYSTONIC REACTION IN TWO PATIENTS, CYP2D6 4/4, 10/10 (POOR) AND 1/5 (INTERMEDIATE) METABOLIZERS.

METOCLOPRAMIDE-INDUCED ACUTE DYSTONIC REACTION IN TWO PATIENTS, CYP2D6 4/4, 10/10 (POOR) AND 1/5 (INTERMEDIATE) METABOLIZERS.

Journal: Psychiatria Danubina

Published: July 22, 2023

Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series.

Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series.

Journal: Pharmacy (Basel, Switzerland)

Published: December 14, 2022

The effects of simvastatin and fenofibrate on malondialdehyde and reduced glutathione concentrations in the plasma, liver, and brain of normolipidaemic and hyperlipidaemic rats.

The effects of simvastatin and fenofibrate on malondialdehyde and reduced glutathione concentrations in the plasma, liver, and brain of normolipidaemic and hyperlipidaemic rats.

Journal: Arhiv za higijenu rada i toksikologiju

Published: December 01, 2022

ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population.

ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population.

Journal: Annals of human biology

Published: November 16, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026